Preliminary research for erectile dysfunction in hemodialysis patients
- VernacularTitle:维持性血液透析患者勃起功能障碍的初步研究
- Author:
Yanbin SHI
;
Dazheng HAN
;
Zhijun ZHAO
- Publication Type:Journal Article
- Keywords:
Hemodialysis;
Sildenafil;
Erectile dysfunction
- From:
Chinese Journal of Nephrology
1997;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To estimate the prevalence of erectile dysfunction (ED) among the patients undergoing manintenance hemodialysis (MHD), and evaluate the efficacy and the adverse effects of sildenafil for ED. Methods The international index of erectile function questionnaire (IIEF) was used to estimate 22 male MHD cases. ED patients were administered sildenafil with the initial dose of 25 mg/d, then maximum of 100 mg/d for 12 weeks. Results 72. 73% (16/22) of MHD patients complained of ED, and the total effective rate of sildenafil was 87.5% (14/16) with common adverse effects-headache and flushing. Conclusion Sildenafil in MHD patients has similar efficacy and safety as the others.
